Competitionin Vivobetween a Cytopathic Variant and a Wild-Type Duck Hepatitis B Virus  by Lenhoff, Raymond J. et al.
Competition in Vivo between a Cytopathic Variant and a Wild-Type Duck Hepatitis B Virus
Raymond J. Lenhoff, Carolyn A. Luscombe, and Jesse Summers1
Department Molecular Genetics and Microbiology, The University of New Mexico School of Medicine, 900 Camino de Salud,
Albuquerque, New Mexico 87131–5276
Received June 18, 1998; returned to author for revision July 22, 1998; accepted August 24, 1998
Several examples of human hepatitis B virus strains with enhanced replication in vitro have been described. To understand
whether this characteristic could be a cause of liver disease, we have studied a variant of the closely related duck hepatitis
B virus (DHBV) that had enhanced levels of cccDNA accumulation, previously shown to be cytopathic in vitro, as a model for
the pathogenesis of analogous viruses in humans. In vivo liver damage caused by this variant (G133E) occurred only during
the first 2 weeks p.i., after which time cccDNA levels and liver histology returned to near normal despite continued virus
replication. To determine whether recovery was due to the emergence of noncytopathic revertant, we tested whether
wild-type virus would have a selective advantage in competition with the cytopathic mutant in a fully infected liver. In a mixed
infection of ducklings with G133E and a small amount of wild-type virus, the wild-type virus was detected as the predominant
genotype after recovery of normal liver histology. Two candidate revertant viral genomes were cloned directly from the serum
virus of G133E-infected birds after recovery and tested for (i) control of cccDNA levels in primary hepatocyte cultures and
(ii) their ability to compete with wild-type virus in a mixed infection. At least one noncytopathic revertant was identified by
these two criteria. The results support the conclusion that the recovery from liver damage in G133E-infected ducklings was
due to the emergence of spontaneous noncytopathic revertants rather than to host suppression of virus cytotoxicity. The
results indicate that acute liver injury may result from infection with a cytopathic hepadnavirus but that such viruses may be
rapidly replaced by noncytopathic variants during persistent infection. © 1998 Academic Press
INTRODUCTION
The hepadnaviruses make up a small family of envel-
oped DNA viruses that replicate through reverse tran-
scription of an RNA intermediate (Mason et al., 1982;
Summers and Mason, 1982; Seeger et al., 1986; Huang
and Summers, 1991). These viruses have double
stranded circular genomes of ;3 kb in size and a simple
genetic structure. They have been described in only a
few hosts, which include humans (Dane et al., 1970;
Robinson et al., 1974; Summers et al., 1975), marmots
(Summers et al., 1978), ground squirrels (Marion et al.,
1980; Testut et al., 1996), and certain waterfowl (Mason et
al., 1980; Sprengel et al., 1988). In all known hosts, hep-
adnaviruses infect primarily hepatocytes and establish a
persistent productive infection of each cell. The mecha-
nism for persistent virus production has been studied in
the duck hepatitis B virus (DHBV) and has been shown to
be due to control of the copy number of viral DNA
molecules that are present in the nucleus of the infected
cell (Tuttleman et al., 1986; Summers et al., 1990, 1991;
Wu et al., 1990; Huang and Summers, 1991; Lenhoff and
Summers, 1994a). This form of viral DNA, covalently
closed circular DNA (cccDNA) serves as the transcrip-
tional template for all new protein synthesis and genome
replication. Copy number control, and thereby control of
replication rate, is exerted by the action of one of the two
envelope proteins, preS, in inhibiting new cccDNA syn-
thesis beyond a small number of molecules that are
formed early in the establishment of infection. It is be-
lieved the preS protein acts by diverting the precursor of
cccDNA, relaxed circular DNA (rcDNA), into a pathway
for assembly of virus particles which are secreted from
the infected cell (Lenhoff and Summers, 1994a).
The control of virus replication rate within the cell has
been postulated to be necessary for persistence of hep-
adnavirus infections at the cellular level, i.e., the lack of
cytopathicity. In recent years, however, HBV strains that
replicate at high levels after transfection of cloned DNA
into heterologous cultured cells have been described
(Moriyama et al., 1996; Pult et al., 1997; Scalglione et al.,
1997; Baumert et al., 1998). The existence of such vari-
ants has prompted speculation that enhanced replica-
tion might be responsible for direct or indirect cytopathic
effects caused by such strains isolated from patients
undergoing severe liver disease. We have examined the
pathogenesis of a strain of DHBV that causes cytopathic
damage in infected ducklings as a model for how anal-
ogous viruses in the human population might behave.
In DHBV, enhanced intracellular virus replication can
be produced by mutations that decrease the ability of the
preS protein to direct rcDNA into the virus assembly
pathway, resulting in the accumulation of excess copies
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of cccDNA in the nucleus. The higher levels of cccDNA
accumulated by cells infected with such variants can
result in eventual cytotoxicity due to unknown causes
associated with enhanced replication (Lenhoff and Sum-
mers, 1994b). One such mutant we have constructed
(G133E) causes acute noninflammatory liver injury in
infected ducklings, presumably due to direct viral cyto-
pathic effects (Lenhoff et al., 1998), but liver injury caused
by G133E infection rapidly regresses even though infec-
tion persists. The mechanism for recovery from acute
liver injury is not known.
In this paper we report the results of experiments
designed to investigate the basis for recovery from acute
liver injury in G133E-infected ducklings. Our evidence
indicates that infection with the cytopathic variant cre-
ates an opportunity for the outgrowth of noncytopathic
revertants and that such noncytopathic revertants arise
during infection. The experiments illustrate the impor-
tance of cccDNA regulation in the mechanism of persis-
tent infection and show how enhanced replication in vitro
does not necessarily confer a selective advantage in a
persistent infection.
RESULTS
In initial studies (Lenhoff et al., 1998) we observed the
occurrence of acute liver injury after infection of duck-
lings with a mutant of DHBV (G133E) shown to be cyto-
pathic in vitro (Lenhoff and Summers, 1994b). The muta-
tion consisted of a single amino-acid substitution in the
preS envelope open reading frame that resulted in di-
minished regulation of cccDNA levels and enhanced
replication in infected primary hepatocytes. Increased
levels of cccDNA in livers of ducklings infected with this
mutant and the occurrence of acute noninflammatory
liver injury were consistent with direct cytotoxic effect of
this virus in vivo, consistent with its phenotype in vitro.
However, ducklings infected with this mutant quickly
recovered from the acute injury, and histology of the liver
returned to near normal despite persistent virus replica-
tion. This finding could be the result of two different
effects: (i) suppression of cytotoxicity by a host response
and (ii) selection and phenotypic dominance of noncyto-
pathic revertants of the infecting virus. The phenotypic
dominance of a revertant in vivo would be aided by the
fact that the mutation that causes diminished cccDNA
regulation in G133E can be complemented by wild-type
preS envelope protein to restore normal cccDNA levels
(Lenhoff and Summers, 1994a). Thus the presence of a
noncytopathic revertant virus that expressed normally
functional preS envelope protein would be expected to
suppress cytopathic injury due to the G133E mutant in a
cell expressing both genomes. For this reason, we tested
whether infection with G133E would allow the outgrowth
of wild-type revertants should they arise spontaneously
and whether such outgrowth coincided with the recovery
from liver injury.
Mixed infection with G133E and wild-type virus
Three groups of ducklings were infected and ana-
lyzed in Experiment 1. In Group I, nine birds were
infected with 109 vge G133E alone. This group was
used to monitor the normal course of the G133E infec-
tion as it was previously reported. In Group II, nine
ducklings were infected with a mixture of 109 vge
G133E and 107 vge wild-type DHBV. This group was
used to determine whether infection with G133E cre-
ated an opportunity for selection of putative wild-type
revertants, simulated by the wild-type virus added to
the inoculum. In Group III, nine ducklings were in-
fected with 109 vge of the mutant P130L mixed with 107
vge wild-type virus. This group served as a control that
wild-type virus did not have a selective advantage over
a phenotypically wild-type genome carrying the ge-
netic marker, the absence of the SmaI site due to the
C1178A mutation. Three birds from each group were
sacrificed at 4, 9, and 21 days p.i. for analysis of
tissues and for histological examination.
The viremias that developed in three birds of each
group are shown in Fig. 1. Viremia achieved a maximum
by Day 2 or 4 p.i. and thereafter fluctuated or declined by
one or two orders of magnitude, as we have previously
observed in experimental infections (Yang and Summers,
1998). Peak viremia coincided with full infection of the
liver. The histological changes seen in the three groups
of birds are summarized in Table 2. Changes in the
appearance of the liver in Groups I and II at 4 days p.i.
were similar to those previously described for G133E
infection. In Group I extensive bile ductule proliferation
was seen in the portal areas with small ductule-like cells
infiltrating into the parenchyma (Figs. 2B and 2E). Similar
but less extensive proliferative changes were seen in
group II livers (Figs. 2C and 2F). Group III livers appeared
normal (Figs. 2A and 2D). In all three groups, virtually all
hepatocytes stained positive for viral preS envelope pro-
tein, while bile ductule and proliferating ductule-like cells
remained negative (Figs 2D–2F). Livers at Days 4 and 9
showed evidence of hepatocellular injury in the form of
apoptotic bodies and necrosis. At Day 21 p.i., livers from
all groups were similar and appeared essentially normal
(Table 2).
To detect enrichment for the added wild-type virus in
the blood of infected ducks from Groups II and III, we
carried out PCR amplification to produce a 664-bp frag-
ment containing the region of the DHBV genome with the
genetic tag; i.e., the presence or absence of the SmaI site
at position 1178. The PCR products were then digested
with SmaI to determine the proportion of wild-type (SmaI
site present) to G133E or P130L virus (SmaI site absent).
As seen in Fig. 3, the PCR product produced from the
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serum of a duckling from Group I (Bird 1) lacked any
detectable SmaI site, whether amplified from serum ob-
tained at 4 or 21 days p.i., as expected. Serum from a
duckling infected with wild-type virus in a parallel exper-
iment (Bird 2) produced a PCR product that was uni-
formly digested with SmaI at both times p.i. In Group II
birds, the PCR product contained little (Birds 3 and 4) or
no (Bird 5) SmaI-digestible DNA at 4 days p.i., but the
PCR product amplified from serum obtained at 21 days
p.i. consisted predominantly of wild-type, SmaI-digestible
DNA molecules. These results indicated that by 21 days
p.i., coincident with recovery from acute liver injury, the
major virus population found in the blood of birds from
Group II had shifted from the G133E virus genotype to the
wild-type genotype. This shift was dependent on the
presence of the G133E mutation itself, since infection
with the P130L noncytopathic strain mixed with wild type
did not provide the opportunity for selection of the wild-
type virus in birds from Group III (Birds 6–8). All diges-
tions were monitored for completeness by means of an
internal control plasmid DNA shown at the top of each
lane.
Characterization of two candidate wild-type revertants
We had previously cloned two candidate wild-type
revertant genomes from the serum of ducklings originally
infected with G133E virus and maintained to days 27 and
72 p.i., beyond the stage of recovery from liver injury (R.
Lenhoff, unpublished). Nucleotide changes in the preS
region of the envelope gene were characterized by se-
quencing and are depicted in Table 1. The single muta-
tions detected in these two genomes were transitions
that occurred within six residues of the original G133E
mutation. In the mutant G133K, the upstream adjacent
residue was changed from G to A, and in G133E/Q133R,
an A at position 1204 was changed from A to G. Both
mutations resulted in the indicated coding changes in
preS and the overlapping P open reading frame. In both
genomes, the original nucleotide substitutions present in
the G133E genome were retained, indicating that these
genomes were most likely revertants derived from the
replicating virus.
The candidate revertants were tested for their replica-
tion phenotype in primary hepatocyte cultures compared
with wild-type virus, G133E virus, and 1165A virus, a
mutant that is totally defective in preS envelope protein
production. LMH cells were transfected with appropriate
head to tail dimers, and virus concentrated from the
supernatants was used to infect primary duck hepato-
cytes. At 10 days p.i., replicative intermediates and
cccDNA were extracted from the infected cell layers and
assayed by Southern blot hybridization. The results,
shown in Fig. 4, compare the levels of cccDNA in each
infected culture with the amount of replicative interme-
diates in the same culture. The phenotype of two mutant
viruses with defects in cccDNA regulation (1165A and
G133E) is indicated by an increase over wild type in the
ratio of cccDNA to rcDNA (60-fold and 4-fold, respective-
ly). By this criterion, the ratio of cccDNA to rcDNA for the
G133E/Q135R mutant was the same as wild type, while
that of the G133K was only slightly higher than wild type.
In this respect, both candidate revertants differed sub-
stantially from the G133E parent.
To test directly for the phenotype of these two candi-
date revertants we performed new series of infections
(Experiment 2) in which each of these mutant viruses
was competed with wild-type virus to determine whether
it behaved like the cytopathic strain, G133E, or like the
noncytopathic strain, P130L, in allowing wild-type virus
outgrowth. Two groups of ducklings were infected, as
previously, with 109 vge each of the test virus (G133K or
G133E/Q135R in Groups I and II, respectively), mixed
with 107 vge of wild-type virus, and viremia was followed
by dot blot hybridization. Livers were removed at 4, 9, and
21 days p.i. for histological examination, and the out-
FIG. 1. Viremia in the three groups of infected ducklings of Experi-
ment 1. The ducklings in each group were bled at the indicated times
and the amount of viral DNA in the serum was determined by dot blot
hybridization. The three birds shown for each group are representative
examples.
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growth of wild-type virus in the blood was monitored by
PCR and SmaI digestion as before. As in Experiment 1,
viremia in the two groups of infected birds, first detected
by dot blot on Day 2 p.i., was observed to decrease or
fluctuate throughout the experiment (Fig. 5). On histolog-
ical examination it was noted that infection with the
G133K mixture (group I) led to bile duct cell proliferation,
abnormal, apoptotic, and lysed hepatocytes and mild
mononuclear cell infiltrates, (Table 2, Fig. 6A). Livers from
birds infected with the G133E/Q135R (group II) mixture
appeared normal (Fig. 6B), except for the presence of
moderate infiltrates of mononuclear cells. At 23 days p.i.
ducklings from Group II showed normal hepatocellular
architecture. In contrast, infected birds from Group I had
evidence of sustained liver damage at Day 23 p.i. The
histological changes in the livers of the two groups of
ducklings in Experiment 2 are summarized in Table 2.
The genotype analysis (Fig. 7) showed that the virus
FIG. 2. Histology and immunohistochemistry of livers from Experiment 1. (A–C) Hematoxylin-eosin stain of livers from Day 4 p.i. of ducklings from
Groups III (A), I (B), and II (C). (D-F) Immunohistochemical stain of preS protein in ducklings at 4 days p.i. from Groups III (D), I (E), and II (F). Arrows
indicate specific features designated PT (portal tract), BD (bile ductule cells).
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population in the G133K-infected ducklings shifted from
the G133K genotype at 4 days p.i. to a mixture of G133K
and wild-type virus at 23 days p.i., reflecting the out-
growth of the wild-type virus added in the inoculum. In
contrast, the wild-type genotype virus was not detected
in birds infected with the G133E/Q135R virus mixture at
23 days p.i. This result indicated that infection with the
G133E/Q135R virus, like the noncytopathic P130L strain
used in the previous experiment, did not allow outgrowth
of wild-type virus, while infection with the G133K pheno-
type allowed wild-type outgrowth, probably due to cyto-
toxicity of the G133K infection.
DISCUSSION
The purpose of this study was to further elucidate the
biological characteristics of cytopathic hepadnaviruses
that might arise in a human population infected with HBV.
As a model for the behavior of such viruses, we have
used a cytopathic mutant of the avian hepadnavirus,
DHBV, to produce chronic infections in ducklings. In this
report, we have examined the basis for the transient
FIG. 6. Liver histology of infected ducklings in Experiment 2. Livers removed at Day 4 p.i. from a duckling infected with G133K 1 WT (A) or
G133E/Q135R 1 WT (B) were stained with hematoxylin and eosin. Arrows indicate the location of the indicated features: BD, bile duct; PT, portal tract;
*A, apoptotic or eosinophilic body.
FIG. 3. PCR assay of viral genotypes in the serum from infected
ducklings of Experiment 1. The region of DHBV DNA between nucleotides
835 and 1478 was amplified by PCR from 2 ml of serum obtained from
ducklings at the indicated times. After PCR, each amplified DNA sample
was mixed with 20 ng of a plasmid DNA containing a single SmaI site as
an internal digestion control, and digested to completion with SmaI. Di-
gestion was monitored by electrophoresis through a 1.5% agarose gel
containing 1 mg/ml ethidium bromide and photographed under ultraviolet
illumination. The positions of the uncleaved (664 bp) and cleaved (363 bp,
301 bp) PCR products, and the cleaved internal control (C) are indicated.
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nature of liver injury induced by infection with the cyto-
pathic strain of DHBV. Specifically, we tested the hypoth-
esis that recovery from acute liver injury was due to the
emergence of noncytopathic revertants during the
chronic phase of infection.
We have used in vivo competition between genotypi-
cally marked viruses with differing cytopathicity to deter-
mine the relative fitness of each virus strain to predom-
inate over the short term in a fully infected liver. Our
experimental design was based on the assumption that
the mixture of the competing genotypes found in the
serum was representative of the virus replicating in the
liver. In Experiment 1, a cytopathic variant of DHBV,
G133E, was capable of spreading after inoculation to
produce a fully infected liver but was thereafter rapidly
replaced by wild-type noncytopathic virus that was
added to the inoculum to simulate the presence of spon-
taneously occurring revertants. Presumably, noncyto-
pathic revertants arising during growth of G133E would
behave in the same way as the added wild-type virus,
i.e., they would outgrow the mutant virus in a fully in-
fected liver. Since the envelope defect in G133E that
presumably gives rise to its cytopathic phenotype can be
complemented in trans by a wild-type envelope protein,
outgrowth of revertants would tend to suppress the cy-
topathic effects of the G133E strain in mixed infected
cells and contribute to recovery of the G133E-infected
duckling from virus-induced liver injury. A weak indica-
TABLE 1
DHBV Mutants Used in this Study
Genome
designation
Nucleic acid
sequence*
Amino acid
sequence†
SmaI site
at 11791188 1205 130 135
Wild type CCA CTC CTG GGA AAT CAG P L L G N Q 1
G133E CCA CTC CTG GAA AAT CAG P L L E N Q 2
P130L CTA CTC CTG GGA AAT CAG L L L G N Q 2
G133K CCA CTC CTG AAA AAT CAG P L L K N Q 2
G133E/Q135R CCA CTC CTG GAA AAT CGG P L L E N R 2
* Numbers indicate nucleotide positions according to Mandart et al., 1984. Underlined letters indicate nucleotide differences with wild type.
† Numbers indicate the corresponding amino acid residues in the preS protein. Underlined letters indicate amino acid differences with wild type.
FIG. 4. Replicative intermediates and cccDNA in primary duck hepato-
cyte cultures. Primary duck hepatocytes were infected at Day 3 after
plating with virus particles concentrated from LMH cell supernatants
transfected with plasmids containing dimers of the indicated genomes.
Virus from the equivalent of 20 ml of LMH cell supernatant was used to
infect each plate, and the cultures were maintained for 10 days before
extraction of the viral DNA. Viral DNA was analyzed by agarose gel
electrophoresis and Southern blot hybridization. The positions of rcDNA,
single-stranded DNA (ssDNA) and cccDNA are indicated. The radioactivity
in the rcDNA band and the cccDNA band were quantitated by phophor-
image analysis and the ratios of cccDNA to rcDNA are indicated.
FIG. 5. Viremias in the two groups of infected ducklings in Experi-
ment 2. The ducklings in each group were bled at the indicated times
and the amount of viral DNA in the serum was determined by dot blot
hybridization. The three birds shown for each group are representative
examples.
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tion of such an effect was noted in the mixed infection
with G133E and wild-type virus since liver injury ap-
peared to be less severe in the mixed infection than in
the single infection with G133E (Table 2). However, more
birds would be needed to document the significance of
the difference we noted in this experiment.
Consistent with the scenario that the outgrowth of
wild-type revertants contributed to the recovery from liver
injury in G133E-infected birds was the isolation of an
apparent revertant, G133E/Q135R, from a recovered
G133E-infected duck. This virus behaved in a manner
that was not distinguished from wild type by (i) its phe-
notype in primary duck hepatocytes, (ii) evidence of liver
injury in infected ducklings, or (iii) its ability to compete
with wild-type virus in fully infected liver (Experiment 2).
A second candidate revertant, G133K, did not seem sig-
nificantly different from wild-type virus in its ability to
control amplification of cccDNA in primary duck hepato-
cytes but was apparently cytopathic in infected animals.
The basis for the outgrowth of this variant is therefore not
apparent. It is possible that coinfection of hepatocytes
with G133K and G133E was less cytopathic than infec-
tion with either virus alone, or that G133K was less
cytopathic than G133E and was therefore capable of
competing with G133E in a fully infected liver. Neither of
these possibilities has been tested.
It is curious that both candidate revertants retained the
original nucleotide substitution of G133E, even when
codon 133 was altered by a second site mutation in
G133K (Table 1). Authentic wild-type revertants presum-
ably could arise by a reversion of A to G at position 1198,
the site of the original G133E mutation, but such rever-
tants were not observed. In direct sequencing reactions
of the PCR products of serum virus in several birds from
preliminary experiments with G133E, the G133K second
site mutation at nucleotide 1197 was observed as a
predominant genotype occupying about 50% of the se-
quence ladder at that position (J. Summers, unpublished
data). We do not know the phenotype of the complete
genomes bearing these second site mutations at residue
1197, and therefore we do not understand the basis for
the apparent repeated selection of this mutation in dif-
ferent birds. The wild-type nucleotide G at position 1198
was not seen in these mixed sequence ladders, indicat-
ing that ‘‘same site’’ reversion to wild type was not a
frequent type of reversion.
It is not entirely clear how wild-type revertant viruses
replace the cytopathic virus in a fully infected liver. We
expect that the cytopathic phenotype of G133E would be
compensated for by its higher replication rate during the
spread of infection, but that in a fully infected liver, where
TABLE 2
Summary of Liver Histology of Infected Ducks in Experiments 1 and 2
Group
Day 4* Day 9 Day 23
BP† EB Ly MNC BP EB Ly MNC BP EB Ly MNC
Experiment 1
I (G133E) 111 1 1 1 111 1 1 1 1 2 2 1
II (G133E 1 WT) 11 1 1 1 11 1 1 1 6 2 2 11
III (P130L 1 WT) 2 2 2 2 2 2 2 6 2 2 2 6
Experiment 2
I (G133K 1 WT) 11 1 1 1 11 1 11 1 11 1 1 1
II (G133E/Q135R 1 WT) 1 2 2 1 2 2 2 11 2 2 2 11
* Estimated severity of liver changes in three birds for each group at the times indicated. The severity noted was representative of that in each bird.
† Features, and grading in cells per mm2 liver section: BP, bile duct epithelial cells and proliferating bile ductule cells; 2, ,150; 1, 150–500; 11,
500–1000; 111, 1000–1500. EB, eosinophilic bodies; 2, ,1; 1, 1–10. Ly, lysed hepatocytes; 2, ,1; 1, 1–150; 11, 150–300. MNC, mononuclear cells;
0, ,100; 1, 100–250; 11, 250–500.
FIG. 7. PCR assay of viral genotypes in the serum from infected
ducklings of Experiment 2. The region of DHBV DNA between nucleo-
tides 835 and 1459 was amplified by PCR from 2 ml of serum obtained
from ducklings at the indicated times. After PCR, each amplified DNA
sample was mixed with 20 ng of a plasmid DNA containing a single
SmaI site as an internal digestion control and digested to completion
with SmaI. Digestion was monitored by electrophoresis through a 1.5%
agarose gel containing 1mg/ml ethidium bromide and photographed
under ultraviolet illumination. The positions of the uncleaved (664 bp)
and cleaved (363 and 301 bp) PCR products and the cleaved internal
control (C) are indicated.
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further spread is limited by the scarcity of uninfected
cells, the longevity of infected cells would become the
factor most beneficial to a virus strain for its survival in
the liver. The population of hepatocytes infected by a
cytopathic strain of virus would surely be decreased by
cell death, thus enriching the liver in cells infected by a
noncytopathic strain; therefore, new hepatocytes formed
in a regenerative response by division of preexisting
hepatocytes would be preferentially derived from the
population infected by a noncytopathic strain. Alterna-
tively, if new hepatocytes were formed from uninfected
stem cells, the two viruses would compete directly for
infection of this cell population. Even in this case, non-
cytopathic revertants would hold an advantage over
G133E because cells infected with G133E alone would
fail to survive, while dually infected cells and cells singly
infected with a noncytopathic revertant would tend to
survive. Whether stable mixed infection of hepatocytes
occurs in vivo is not known, however. Both mechanisms
for replacement of G133E by wild-type virus imply a large
amount of hepatocellular turnover during replacement. If
G133E virus were completely unable to infect new cells,
a minimum of 50% of the cells in the liver would still have
to die and be replaced by wild-type virus-infected cells to
account for the amount of replacement observed in Ex-
periment 1. Any residual ability of G133E virus to compete
with wild-type virus for infection of new hepatocytes or
for outgrowth of regenerating hepatocytes would neces-
sitate even higher amounts of cell death to account for
the observed replacement. A kinetic model of this pro-
cess indicates that the amount of cell death involved in
50% replacement of G133E by wild-type virus after full
infection of the liver might be as high as two to three
times the starting number of liver cells (J. Summers,
unpublished data available on request).
The mechanism responsible for cytotoxicity of the
G133E virus is not known. In a previous study (Lenhoff
and Summers, 1994b), cytotoxicity among a series of
mutants defective in cccDNA regulation was directly
proportional to the severity of their regulation defect.
Whether it is the accumulation of cccDNA itself, the
accumulation of some viral gene product, or some other
behavior of the mutant preS protein that also affects its
ability to regulate cccDNA that mediates cell injury is not
known. The apparent cytotoxic phenotype of G133K virus
did not correlate with a seemingly significant increase in
cccDNA levels, compared with other mutants, but abso-
lute levels of cccDNA per cell were not directly mea-
sured in these experiments. For this reason, the exact
phenotype of G133E and G133K mutants that is respon-
sible for the cytopathic property of the two viruses is a
matter of conjecture.
The experiments reported here support the hypothesis
that outgrowth of wild-type revertants contributed to the
recovery of G133E-infected birds from acute liver injury.
These data do not directly refute an alternative second
hypothesis, that a host response suppressed the cyto-
toxicity of G133E infection in individual hepatocytes. In
our view, however, these two hypotheses are mutually
exclusive if cytotoxicity of the G133E strain is the factor
that provides the opportunity for outgrowth of wild-type
virus. Thus suppression of cytotoxicity by a host re-
sponse would tend to remove the selective pressure for
outgrowth of wild-type virus, which clearly exists, accord-
ing to our experiments, in G133E-infected liver. For this
reason, our data favor the outgrowth of noncytopathic
revertants as the major mechanism for recovery of
G133E-infected birds from acute liver injury. It follows
that cytopathic variants in which reversion was not so
readily achieved or in which cytotoxicity could not be
suppressed by complementation in trans might be capa-
ble of causing a more chronic liver injury by direct cyto-
toxicity.
The results of this study illustrate some limitations on
the potential of cytopathic variants of HBV, even with an
enhanced replication rate, to cause persistent infection
and chronic liver disease in humans. While such variants
may efficiently spread in the liver following transmission,
it can be predicted that they would be at a disadvantage
for persistence in competition with similar but noncyto-
pathic strains of HBV such as, for example, spontane-
ously arising revertants.
MATERIALS AND METHODS
Plasmids and mutant genomes
The DHBV genome used in these studies was that
sequenced by Mandart (Mandart et al., 1984). Site-di-
rected mutagenesis was used to produce a DHBV vari-
ant with altered regulation of cccDNA synthesis. This
mutant, G133E, containing single nucleotide changes at
two sites, has already been described (Lenhoff and Sum-
mers, 1994a,b). One mutation was silent in the overlap-
ping P open reading frame but resulted in a single
amino-acid substitution of glycine to glutamic acid at
position 133 (G133E) in the large envelope protein. A
second change at nucleotide 1178 from C to A (C1178A)
was silent in both the preS and P open reading frames
but destroyed the SmaI site at this position and was
therefore useful as a convenient genetic tag. A second
mutant, P130L, was used as a wild-type control in these
studies (Lenhoff and Summers, 1994a). P130L was gen-
erated in vitro by substitution of the C residue at nucle-
otide position 1189 with T, causing a change of codon
130 from P to L (CCA3CTA). This mutant also retained
the C1178A mutation as a genetic tag. Two spontane-
ously occurring variant genomes (G133K and G133E/
Q135R) cloned directly from infected duck sera (R. Len-
hoff, unpublished observations) were subcloned as
head-to-tail dimers in plasmid pSP65. SmaI digestion
and sequencing of these genomes from nucleotide 800
to 1285 confirmed that they were derived from G133E and
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revealed the location of mutations in preS that were
presumably responsible for their altered phenotypes. In
one case, the original nucleotide substitution (G133K)
resulting in the G133E mutation (GGA3GAA) was re-
tained while codon 133 was altered to encode lysine
(GAA3AAA) and the overlapping P open reading frame
codon was changed from glycine to glutamic acid
(GGA3GAA). In the variant G133E/Q135R, the original
mutation was retained while the codon at position 135
was changed from Q to R (CAG3CGG). The mutation at
this site did not result in a change in P protein coding.
Cloning of candidate revertant genomes
Viral relaxed circular DNA (ca. 1 ng) was purified
(Lenhoff and Summers, 1994b) from serum taken from
two G133E virus-infected birds at 24 and 72 days p.i.,
respectively. The viral DNA was linearized with EcoRI,
ligated to a 50-fold excess of EcoRI-linearized pSP65
plasmid, and transformed into Escherichia coli strain
DH5-a. Two DHBV genomes that were candidate rever-
tants were identified by SmaI digestion, sequenced be-
tween nucleotides 800 and 1279 (preS region), and
cloned as head to tail dimers in pSP65. Dimers were
used for transfection of LMH cells.
Antibodies
The DHBV core protein specific rabbit antiserum used
in the present study was previously described (Calvert
and Summers, 1994). A DHBV preS reactive antibody
was prepared as described (Luscombe et al., 1994).
Secondary antibodies reactive to the DHBV specific an-
tibodies conjugated to horse-radish peroxidase were ob-
tained a commercial source (Pierce, Rockford, IL).
Cell culture and transfection
Virus particles for infection of either primary duck
hepatocytes or ducklings were produced by transfection
of the chicken hepatoma cell line LMH (Kawaguchi et al.,
1987) as previously described (Summers et al., 1991).
Supernatants from the transfected LMH cells were col-
lected daily from Days 3–10 posttransfection, clarified by
centrifugation at 10,000 rpm for 10 min and stored prior to
use at 4°C. Virus was concentrated by precipitation with
polyethylene glycol (10% final concentration) followed by
centrifugation and dissolved in a suitable volume. The
titer of virus expressed in viral genome equivalents (vge)
was determined by Southern blot hybridization following
selective DNA extraction of enveloped virus particles as
previously described (Lenhoff and Summers, 1994a). Vi-
ral DNA was quantitated by comparison of the hybridiza-
tion signal from the equivalent of 1 ml medium from
transfected LMH cells to a 300-pg hybridization standard
using a scanning image analyzer (Molecular Diagnos-
tics, Sunnyvale, CA). The number of pg of viral DNA per
ml of LMH cell medium was then converted to vge per ml
using a molecular weight for viral DNA of 2 3 106 Da.
Animals
Day-old ducklings were obtained from Metzer Farms
(Redland, CA). Blood was collected at 1 day posthatch
and the serum was assayed by dot blot hybridization for
DHBV DNA. Primary hepatocyte cultures were prepared
from DHBV negative ducklings 7–10 days of age as
previously described (Tuttleman et al., 1986). Infection for
primary hepatocytes was carried out at 2 days postplat-
ing by addition of concentrted virus to the culture me-
dium, which remained in contact with the cells for 20 h at
37°C. The culture medium, containing 1% dimethylsulf-
oxide (Pugh and Summers, 1989), was renewed daily.
For infection studies, DHBV-free ducklings were inoc-
ulated by intraperitoneal injection on Day 2 posthatch
with either G133E at a dose of 109 vge or with a mixture
of 109 vge of G133E, G133K, G133E/Q135R, or P130L,
respectively, combined with 107 vge wild-type DHBV.
Three birds from each group were sacrificed at Days 4,
9, and 21 p.i. Animals were killed by intravenous injection
with phenobarbitol (68 g/ml) and their livers removed for
virological and histological examination. All birds re-
ceived humane care throughout the study in accordance
with guidelines issued by the National Institutes of
Health.
Analysis of viral DNA in the serum
Viremia was assayed daily for the first week and on
alternate days for the next 2 weeks of each study. DHBV
DNA in the serum was detected by dot blot hybridization.
Serum (1 ml) was applied to a nylon filter (Hybond N,
Amersham) and air dried. Viral DNA, was released by
1-min treatment with alkali (0.2 N NaOH) followed by
neutralization in 0.2 N Trizma HCl. The filter was dried a
second time and DHBV DNA was detected using a 32P-
labeled riboprobe specific for the detection of the viral
minus strand (Pugh et al., 1988). The amount of radioac-
tive probe binding to serum-derived DHBV DNA was
determined by comparison to a DHBV DNA standard on
the same filter using phosphorimaging analysis (Molec-
ular Diagnostics).
Purification and detection of viral DNA genomes in
the serum using PCR
Amplification was performed on DNA isolated for the
equivalent of 2 ml serum. Serum (10 ml) was mixed with
40 ml of TE 10:1 containing 2% SDS, 20 mg of Pronase,
and 100 mM NaCl. The mixture was incubated for 60 min
at 37 °C and then extracted with phenol. Nucleic acids
were precipitated by the addition of 2 volumes of 100%
ethanol and collected by microcentrifugation. The pellet
was washed with ethanol, dried, and dissolved in 5 ml of
TE 10:1, and 1 ml was used for polymerase chain reaction
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(PCR). PCR was performed using as the plus strand
primer an oligonucleotide nucleotide containing the
DHBV sequence from position 816–834 and a minus
strand primer with the DHBV sequence from nucleotide
1479–1459. A 664-bp fragment was produced from the
viral DNA template using AmpliTaq Gold (Perkin-Elmer)
and 30 amplification cycles in a Perkin-Elmer 9600. In
products derived from wild-type DHBV, this 664-bp PCR
product contained a single SmaI site; however, this site
was absent in PCR products amplified from the P130L,
G133E, G133K, or G133E/Q135R genomes. The presence
or absence of the SmaI site was used to determine the
genotype of the serum virus.
Assay of replicative intermediates and cccDNA in
primary duck hepatocytes
DHBV DNA replicative intermediates were selectively
extracted from primary duck hepatocyte cultures as pre-
viously described (Lenhoff and Summers, 1994b). Sam-
ples were analyzed by electrophoresis through a 1%
agarose gel and transferred to a nylon filter. Viral DNA
was detected by hybridization with a 32P-labeled ribo-
probe specific for detection of the viral DNA minus
strand.
Immunohistochemical detection of viral proteins in
the liver
Fresh liver specimens were fixed for 30 min in ethanol:
acetic acid (3:1) (EAA) and processed and embedded in
paraffin using standard laboratory methods. Liver sec-
tions 4 mm in thickness were prepared, placed onto
microscope slides, and hydrated through xylene and a
graded alcohol series. Endogenous peroxidase was
blocked by incubation in methanol containing 10% H2O2
for 30 min. To prevent nonspecific antibody binding,
sections were blocked in 10% goat serum in 2 mM
HEPES buffer, pH 7.4, containing 0.15 M NaCl (HBS) for a
further 15 min. Primary antibodies specific for DHBV core
or preS proteins were incubated on the liver sections for
60 min at room temperature. Unbound antibody was
removed with three 5-min washes with HBS. The primary
antibody was detected using the appropriate horse-rad-
ish peroxidase-conjugated goat secondary antibody
(Pierce) for 60 min at room temperature.
Viral protein-antibody complexes was visualized by
immunoperoxidase detection using diaminobenzidine
(DAB) (Pierce) according to the manufacturer’s instruc-
tions. All sections were counterstained with Mayer’s he-
matoxylin. Sections were mounted with Cytoseal 60
(Cornwell Corp., Riverdale, NJ).
Grading of histological features was performed by
examination of hemotoxylin-eosin stained sections of
paraffin embedded EAA-fixed tissue. Slides were graded
in comparison to reference slides that had been previ-
ously characterized by morphometric analysis for degree
of bile ductule proliferation, eosinophilic bodies (presum-
ably as a result of apoptosis), hepatocellular lysis, and
mononuclear cell infiltration, as previously described
(Lenhoff et al., 1998).
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